Altimmune, Inc. (ALT): Depreciation & Amortization

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Depreciation & Amortization is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

-$205.0K
Year ended 2022-12-31
$551.0K2021-12-31: $551.0K2022-12-31: -$205.0K-$205.0K
2021-12-31 Depreciation & Amortization (USD) 2022-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2022-12-31-$205.0Kn/m2023-02-28, From 2022-01-01
2021-12-31$551.0Kn/a2023-02-28, From 2021-01-01